Investigating the effect of injectable Acetaminophen in the treatment of Patent Ductus Arteriosus (PDA).

Phase 3

• Conditions: eonatal Patent Ductus Arteriosus.; Patent ductus arteriosus; Q25.0

• Registration Number: IRCT20230219057459N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

All hospitalized neonates with Patent Ductus Arteriosus(PDA)
All term neonates with a gestational age of 37 weeks and more
The minimum age is 3 days and the maximum age is 28 days.

Exclusion Criteria

Congenital Heart Disease
Multiple Congenital Anomalies
Life Threatening Disease
Asphyxia
Lack of parental consent

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Closure of patent ductus arteriosus in neonates. Timepoint: Opening of the ductus arteriosus: before the start of the study and on the third day and the sixth day after receiving injectable acetaminophen. Method of measurement: Eco cardiography.